Literature DB >> 8462973

A missense mutation in the low density lipoprotein receptor gene causes familial hypercholesterolemia in Sephardic Jews.

E Leitersdorf1, A Reshef, V Meiner, E J Dann, Y Beigel, F G van Roggen, D R van der Westhuyzen, G A Coetzee.   

Abstract

Familial hypercholesterolemia (FH) is an autosomal dominant disease caused by mutations in the low density lipoprotein (LDL) receptor gene. Here, we characterize an LDL receptor mutation that is associated with a distinct haplotype and that causes FH in the Jewish Sephardic population originating from Safed, a town in northern Israel. The mutation was found in eight FH families originating from this community comprising 10% of heterozygote FH index cases screened in Israel. The mutation was not found in four additional FH heterozygotes whose hypercholesterolemia co-segregated with an identical LDL receptor gene haplotype. A guanine to cytosine substitution results in a missense mutation (asp147 to his) in the fourth repeat of the binding domain encoded by exon 4 of the LDL receptor gene. The mutant receptor protein was synthesized in cultured cells as a 120 kDa precursor form that failed to undergo normal processing to a mature cell surface form. Most of the receptor precursors were degraded in the endoplasmic reticulum. The small number of mutant receptors on the cell surface were unable to bind LDL or beta very low density lipoprotein. The abnormal behavior of the mutant receptor was reproduced by site-directed mutagenesis and expression of the mutant protein in CHO cells. The mutation can be diagnosed by allele-specific oligonucleotide hybridization of polymerase chain reaction amplified DNA from FH patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8462973     DOI: 10.1007/bf00222714

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  36 in total

Review 1.  The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein.

Authors:  H H Hobbs; D W Russell; M S Brown; J L Goldstein
Journal:  Annu Rev Genet       Date:  1990       Impact factor: 16.830

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

Review 3.  A receptor-mediated pathway for cholesterol homeostasis.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

4.  The Lebanese allele at the low density lipoprotein receptor locus. Nonsense mutation produces truncated receptor that is retained in endoplasmic reticulum.

Authors:  M A Lehrman; W J Schneider; M S Brown; C G Davis; A Elhammer; D W Russell; J L Goldstein
Journal:  J Biol Chem       Date:  1987-01-05       Impact factor: 5.157

5.  Different combinations of cysteine-rich repeats mediate binding of low density lipoprotein receptor to two different proteins.

Authors:  D W Russell; M S Brown; J L Goldstein
Journal:  J Biol Chem       Date:  1989-12-25       Impact factor: 5.157

6.  Posttranslational processing of the LDL receptor and its genetic disruption in familial hypercholesterolemia.

Authors:  H Tolleshaug; J L Goldstein; W J Schneider; M S Brown
Journal:  Cell       Date:  1982-10       Impact factor: 41.582

7.  A nonsense mutation in the LDL receptor gene leads to familial hypercholesterolemia in the Druze sect.

Authors:  D Landsberger; V Meiner; A Reshef; Y Levy; D R van der Westhuyzen; G A Coetzee; E Leitersdorf
Journal:  Am J Hum Genet       Date:  1992-02       Impact factor: 11.025

8.  A common Lithuanian mutation causing familial hypercholesterolemia in Ashkenazi Jews.

Authors:  V Meiner; D Landsberger; N Berkman; A Reshef; P Segal; H C Seftel; D R van der Westhuyzen; M S Jeenah; G A Coetzee; E Leitersdorf
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

9.  Ammonium chloride causes reversible inhibition of low density lipoprotein receptor recycling and accelerates receptor degradation.

Authors:  K I Grant; L A Casciola; G A Coetzee; D A Sanan; W Gevers; D R van der Westhuyzen
Journal:  J Biol Chem       Date:  1990-03-05       Impact factor: 5.157

10.  Monoclonal antibodies to the low density lipoprotein receptor as probes for study of receptor-mediated endocytosis and the genetics of familial hypercholesterolemia.

Authors:  U Beisiegel; W J Schneider; J L Goldstein; R G Anderson; M S Brown
Journal:  J Biol Chem       Date:  1981-11-25       Impact factor: 5.157

View more
  8 in total

1.  Software and database for the analysis of mutations in the human LDL receptor gene.

Authors:  M Varret; J P Rabès; G Collod-Béroud; C Junien; C Boileau; C Béroud
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

2.  Sequence diversity in genes of lipid metabolism.

Authors:  C K Garcia; G Mues; Y Liao; T Hyatt; N Patil; J C Cohen; H H Hobbs
Journal:  Genome Res       Date:  2001-06       Impact factor: 9.043

3.  Efficacy and safety of high dose fluvastatin in patients with familial hypercholesterolaemia.

Authors:  E Leitersdorf; S Eisenberg; O Eliav; N Berkman; E J Dann; D Landsberger; E Sehayek; V Meiner; T K Peters; E N Muratti
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  Molecular characterization of minor gene rearrangements in Finnish patients with heterozygous familial hypercholesterolemia: identification of two common missense mutations (Gly823-->Asp and Leu380-->His) and eight rare mutations of the LDL receptor gene.

Authors:  U M Koivisto; J S Viikari; K Kontula
Journal:  Am J Hum Genet       Date:  1995-10       Impact factor: 11.025

5.  Gender-related response to fluvastatin in patients with heterozygous familial hypercholesterolaemia.

Authors:  E Leitersdorf
Journal:  Drugs       Date:  1994       Impact factor: 9.546

6.  Characterization of low density lipoprotein receptor (LDLR) gene mutations in Albania.

Authors:  Maria Diakou; George Miltiadous; Stavroula Xenophontos; Marios Cariolou; Nevila Heta; Irena Korita; Anyla Bulo; Etleva Refatllari; Eleni Bairaktari; Moses Elisaf
Journal:  Arch Med Sci       Date:  2010-04-30       Impact factor: 3.318

Review 7.  Validation of LDLr Activity as a Tool to Improve Genetic Diagnosis of Familial Hypercholesterolemia: A Retrospective on Functional Characterization of LDLr Variants.

Authors:  Asier Benito-Vicente; Kepa B Uribe; Shifa Jebari; Unai Galicia-Garcia; Helena Ostolaza; Cesar Martin
Journal:  Int J Mol Sci       Date:  2018-06-05       Impact factor: 5.923

Review 8.  Cell biology of membrane trafficking in human disease.

Authors:  Gareth J Howell; Zoe G Holloway; Christian Cobbold; Anthony P Monaco; Sreenivasan Ponnambalam
Journal:  Int Rev Cytol       Date:  2006
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.